Role of Glucose Metabolism in Migration of Cutaneous Dendritic Cells in Psoriasis

Exclusion Criteria

• •Minor or incapable or unwilling to consent freely or in an informed manner Pregnant or nursing woman.
• •Patient in a period of exclusion from other biomedical research
• •Patient with generalized chronic inflammatory disease or other inflammatory dermatosis
• •Patients on general corticosteroid, immunomodulator or immunosuppressant therapy in the month prior to local inclusion or treatment with corticosteroid therapy in the 15 days prior to inclusion, on anti- treatmentIL-23 or anti IL12/23 for less than 3 months or under anti-IL-17 or anti-TNF treatment for less than 1 month.
• •Contraindication to cutaneous biospsis (known hemostasis disorder, taking anticoagulants, allergy to xylocaine, history of cheloid scars, congenital immune deficiency)